Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Pingal Desai

Sports Medicine Liberal, KS Medical Doctor

NPI 1629399829 CMS profile 893277

305 W 15Th St Ste 102, Liberal, KS 67901

Open in the dashboard

General payments

$19,272

94 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Pingal Desai of Liberal, KS is reported in the CMS Open Payments database as having received $19,272 across 94 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 68th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,925 17
2024 General $2,059 11
2023 General $5,083 22
2022 General $3,014 18
2021 General $3,649 14
2020 General $1,380 2
2019 General $1,161 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Pingal Desai
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Pingal Desai were reported at $2,925. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Pingal Desai Sports Medicine median Middle half National median
2019 $1,161 $1,176 $199–$4,249 $163
2020 $1,380 $708 $96–$2,890 $114
2021 $3,649 $1,213 $152–$3,994 $132
2022 $3,014 $1,230 $159–$3,998 $149
2023 $5,083 $584 $146–$2,836 $160
2024 $2,059 $628 $163–$3,168 $164
2025 $2,925 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $10,305 48 payments
  2. Medacta USA, Inc. $3,109 11 payments
  3. Titan Surgical Group, LLC $2,563 2 payments
  4. Arthrex, Inc. $1,496 3 payments
  5. Stryker Corporation $1,202 9 payments
  6. Smith+Nephew, Inc. $209 7 payments
  7. SeaPearl Inc $73 1 payment
  8. DePuy Synthes Sales Inc. $61 1 payment
  9. Sumitomo Pharma America, Inc. $54 2 payments
  10. Innovation Technologies Inc $31 1 payment
  11. Other $169 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $12,308 37 payments
  2. Education $3,763 3 payments
  3. Food and Beverage $3,201 54 payments
Products named General payments · program years 2019–2025
  1. Avenir $2,672 11 payments
  2. AMISTEM $1,681 6 payments
  3. Persona $1,554 5 payments
  4. Comprehensive Shoulder System $1,549 5 payments
  5. Arcos $1,486 3 payments
  6. MAKO $1,001 5 payments
  7. ROSA $869 10 payments
  8. GMK SPHERE $850 1 payment
  9. Persona Revision $832 7 payments
  10. PRIMARY SHOULDER $449 2 payments
  11. Other $1,221 38 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

252

Median for Orthopedic Surgery: 203

Drug cost

$2,044

Median for Orthopedic Surgery: $1,433

Branded share of claims

27%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 20 $597
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 46 $376
Doxycycline Hyclate Generic 37 $338
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 22 $241
Tramadol Hcl Generic 60 $153
Naproxen Generic 32 $145
Mupirocin Generic 18 $125
Cyclobenzaprine Hcl Generic 17 $69

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 108 billing codes

Paid by Medicare

$127,493

Of which drugs: $1,383

Medicare patients

313

Average age 74

Services billed

6,785

185 women, 128 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 74%
Diabetes 40%
Depression 28%
Ischemic heart disease 25%
Chronic kidney disease 23%
COPD 23%
Heart failure 21%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 62 5,454 $540
Injection, methylprednisolone acetate, 80 mg J1040 Office 17 22 $133

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

94 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record